CVS Health Corp.'s $68 billion merger with Aetna Inc. could stop emerging pharmacy benefit services from entering an already consolidated market, industry participants and observers told Bloomberg Law.
The deal cleared federal antitrust regulators Oct. 10, with Justice Department antitrust chief Makan Delrahim touting the vertical integration of a pharmacy and health benefits company as a bonus for consumers. The DOJ cleared a similar deal in Cigna Corp.'s $54 billion takeover over Express Scripts Holding Co. in September.
Critics say integration like this will highlight exiting problems in an important part of the healthcare market — connecting pharmacies with insurance ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.